This inventor holds 2 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignee: Conaris Research Institute. Active years: 2010-2019.
Company Filing History:
Years Active: 2010-2019
Title: Georg Waetzig: Innovator in Pharmaceutical Research
Introduction
Georg Waetzig is a notable inventor based in Kiel, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that positively influence human health. With a total of 2 patents, his work is recognized for its innovative approach to addressing medical challenges.
Latest Patents
Waetzig's latest patents include a pharmaceutical composition containing nicotinic acid, nicotinamide, and tryptophan aimed at positively influencing the intestinal microbiota. This invention focuses on a new formulation that can be released in the small or large intestine, enhancing gut health. Another significant patent involves soluble GP130 molecule variants that serve as a medicament. This polypeptide-dimer is designed to improve production rates in host cells and offers advantages in purification and binding to IL-6/soluble IL-6 receptor complexes.
Career Highlights
Georg Waetzig is associated with Conaris Research Institute, where he has been instrumental in advancing pharmaceutical research. His innovative work has positioned him as a key figure in the development of new medical treatments.
Collaborations
Waetzig collaborates with notable colleagues such as Dirk Seegert and Nikolaus Rahaus, contributing to a dynamic research environment that fosters innovation.
Conclusion
Georg Waetzig's contributions to pharmaceutical research exemplify the impact of innovation in medicine. His patents reflect a commitment to improving health outcomes through scientific advancement.